Association of Vascular Endothelial Growth Factor (VEGF) and Mammalian Target of Rapamycin (mTOR) with Radiotherapy Response in High-Grade Sarcomas
| Autor: | Eny Soesilowati, Afiati Afiati, Herry Yulianti, Bethy Suryawathy Hernowo, Adji Kusumadjati |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Indonesian Journal of Cancer. 16:81 |
| ISSN: | 2355-6811 1978-3744 |
| DOI: | 10.33371/ijoc.v16i2.868 |
| Popis: | Background: Sarcoma is a rare malignant aggressive tumor originating from mesenchymal elements. High-grade sarcoma has a poor prognosis. The mortality rate of high-grade sarcomas is 50–75%. Radiotherapy is needed in high-grade sarcoma. Radioresistance in the high-grade sarcoma is still common. Vascular endothelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) are molecular markers that play a role in radioresistance. This study aimed to analyze the association of VEGF and mTOR with radiotherapy response in high-grade sarcoma. Method: This study was an analytic observational study with a cross-sectional design. The minimum samples based on Lameshow’s formula included 40 selected paraffin-embedded tissue blocks from biopsy high-grade sarcoma, consisting of 20 samples of radioresistance and 20 samples of radiosensitive. Immunohistochemistry staining for VEGF and mTOR were performed on all samples. Statistical analysis used the Chi-Square test. The significance of the data was obtained when p-value |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|